Drug Discovery Innovations - Cell Based Assays, Phenotypic Screening and Pioneering Technologies will provide you with the latest leading-edge strategies being pursued to improve target identification and validation in early stage drug discovery and to improve R&D efficiency. The programme will address issues, breakthroughs and developments to improve your day to day role, identifying better quality candidate drugs to increase translation to clinical results. New biology continues to emerge at a fast pace and is revealing many new and exciting therapeutic opportunities for drug discovery scientists; potential novel drug targets and new mechanisms-of-action. It is critical that the drug discovery field continually adapts and equips with new technologies and innovations that will enable targets to be prosecuted no matter which direction the cutting-edge biology has taken. Hence the 2019 ELRIG R&I conference will discuss how the most promising new biology is being identified and discovered and seek to explore what promising new technologies and innovations are emerging to enable this science to be effectively translated into successful therapeutics.